Table 1.
Relationship between preoperative serum hs-CRP and clinicopathological characteristics of GC patients.
| Variables | Aggregate (n=628) | hs-CRP<1mg/L (n=299) | hs-CRP≥1mg/L (n=329) | χ2/U Value | P Value |
|---|---|---|---|---|---|
| Age(y) | – | 52.0 (45.0,60.0) | 60.0 (51.0,67.0) | 33363.0 | <0.001 |
| Gende r(n) | |||||
| Male | 400 | 180 | 220 | 3.012 | 0.083 |
| Female | 228 | 119 | 109 | ||
| Grade (n) | |||||
| Well/moderate | 153 | 72 | 81 | 0.025 | 0.875 |
| Poor/undifferentiated | 475 | 227 | 248 | ||
| TMD(n) | |||||
| <5cm | 424 | 230 | 194 | 23.029 | <0.001 |
| ≥5cm | 204 | 69 | 135 | ||
| PNI(n) | |||||
| No | 377 | 197 | 180 | 8.153 | 0.004 |
| Yes | 251 | 102 | 149 | ||
| LVI(n) | |||||
| No | 384 | 204 | 180 | 12.045 | 0.001 |
| Yes | 244 | 95 | 149 | ||
| DTI(n) | |||||
| T0/T1 | 146 | 95 | 51 | 29.893 | <0.001 |
| T2 | 96 | 49 | 47 | ||
| T3 | 183 | 65 | 118 | ||
| T4 | 203 | 90 | 113 | ||
| LNM(n) | |||||
| N0 | 214 | 125 | 89 | 15.487 | 0.001 |
| N1 | 109 | 47 | 62 | ||
| N2 | 113 | 45 | 68 | ||
| N3 | 192 | 82 | 110 | ||
| pTNM stages(n) | |||||
| 0/I/II | 311 | 172 | 139 | 14.622 | <0.001 |
| III/IV | 317 | 127 | 190 |
hs-CRP, hypersensitive C-reactive protein; TMD, tumor maximum diameter; PNI, peripheral nerve invasion; LVI, lymph-vascular invasion; DTI, depth of tumor invasion; LNM, lymph node metastasis.